PNT2258 not checked
Sierra Oncology LLC - a GSK company · BCL2 targeted therapy
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
4 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Patients will receive PNT2258 as an intravenous infusion once daily for 5 consecutive days (Days 1-5) of every 21-day cycle (3 weeks). The treatment cycle repeats every 3 weeks for up to 6 cycles in the absence of disease progression, unacceptable toxicity, or patient withdrawal from the study.”In the company’s words, NCT01191775 on ClinicalTrials.gov
- Tested for
- Richter's Transformation, Lymphoma, Diffuse Large B-Cell, Lymphoma, Non-Hodgkin's, Cancer, Lymphoma, Prostate Cancer, Melanoma
- Main trialPhase 2
- “This study is sponsored by Sierra Oncology, Inc. formerly ProNAi Therapeutics, Inc. It is a multi-center, single-arm, 2-stage, open-label phase II investigation of PNT2258 to characterize anti-tumor activity and collect safety data on patients with Richter's Transformation.”In the company’s words, NCT02378038 on ClinicalTrials.gov
- Other names
- DNAi · BCL2 targeted therapy
Other drugs for Richter's Transformation
- GlofitamabRoche · Phase 3
- ObinutuzumabRoche · Phase 3
- TocilizumabRoche · Phase 3
- IbrutinibJohnson & Johnson (Janssen) · Phase 3
- SelinexorKaryopharm Therapeutics Inc · Phase 2/3
- XNW5004Evopoint Biosciences Inc. · Phase 3
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Terminated | Jun 2016 | PNT2258 for Treatment of Patients With Richter's Transformation (Brighton) | |
| Phase 2Completed | 11 Jul 2016 | PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) | |
| Phase 2Completed | Aug 2016 | Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma | |
| Phase 1Completed | Apr 2012 | A Study of PNT2258 in Patients With Advanced Solid Tumors |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026